Literature DB >> 18475175

Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes.

Fawzy A Elbarbry1, Travis Marfleet, Ahmed S Shoker.   

Abstract

Frequency of drug-drug interaction is high in most solid organ transplant recipients because of polypharmacy. These interactions involve, predominantly, the cytochrome P450 (CYP) enzymes. Several reviews described these interactions, but few focused on how these interactions are evaluated. This review summarizes current in vitro functional assays of CYP activity to assist in understanding the bidirectional relationship between immunosuppressants and CYP enzyme system. To achieve our goal we describe the constituents of CYP system followed by discussing their role in the common immunosuppressive drug-drug interactions. We also present the various in vitro assays used to evaluate modulation of CYP enzyme activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18475175     DOI: 10.1097/TP.0b013e31816fc03b

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

Review 1.  [Clinically relevant pharmacokinetic drug interactions in the intensive care unit: an overview].

Authors:  W Kämmerer
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-23       Impact factor: 0.840

2.  Effect of Dietary Doses of Quercetin on Hepatic Drug Metabolizing Enzymes in Spontaneously Hypertensive Rats.

Authors:  Fawzy Elbarbry; Aimy Ung; Deepa Rao; Khaled Abdelkawy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

3.  Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Samer K Khaled; Joycelynne M Palmer; Josef Herzog; Tracey Stiller; Ni-Chun Tsai; David Senitzer; Xueli Liu; Sandra H Thomas; Sepideh Shayani; Jeffrey Weitzel; Stephen J Forman; Ryotaro Nakamura
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-30       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.